Eshelman Innovation
Roy Zwahlen is an accomplished professional currently serving as Chief Strategy Officer at Eshelman Innovation, overseeing a $100MM moon-launch fund focused on therapeutic and digital health projects. Zwahlen has held significant academic leadership roles at the UNC Eshelman School of Pharmacy, including Associate Dean of Strategic Partnerships and Risk Management, where strategic risk management processes were developed, and Associate Dean of Innovation, Entrepreneurship, and Risk Management, successfully leading the Eshelman Institute from startup to scale. Zwahlen's prior experience includes roles such as Interim Director of Operations at READDI, and Director of Technology Transfer and Associate Counsel at the Biotechnology Industry Organization, featuring expertise in research translation and technology licensing. Additional contributions include serving as a magistrate in Virginia and participating as a Fulbright Specialist at Monash University, focusing on evaluating innovation ecosystems. Education includes a Juris Doctor from George Mason University and a BA in Political Science from Brigham Young University.
This person is not in any offices
Eshelman Innovation
Eshelman Innovation is an innovation engine that turns great ideas into healthcare products and services that improve lives in North Carolina and throughout the world. Our Therapeutics Accelerator has driven novel solutions to unmet needs in oncology, neuroscience and infectious diseases. Our Venture Studio nurtures game-changing digital health startups to combat harms caused by opioid use disorder, food insecurity and more. At Eshelman Innovation, even when we encounter the most difficult healthcare problems, we don’t back away. We charge toward them.